Share via:
A federal jury in California has sided with Masimo in a patent battle with Apple over Apple Watch’s blood oxygen feature. The jury awarded Masimo $634 million in damages and concluded that Apple infringed on a Masimo patent covering low power pulse oximeter features.
As explained by Daily Journal, much of the case centered on whether Apple Watch can be categorized as a “patient monitor” per Masimo’s patent.
Apple argued that the “patient monitor” term refers only to…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
A federal jury in California has sided with Masimo in a patent battle with Apple over Apple Watch’s blood oxygen feature. The jury awarded Masimo $634 million in damages and concluded that Apple infringed on a Masimo patent covering low power pulse oximeter features.
As explained by Daily Journal, much of the case centered on whether Apple Watch can be categorized as a “patient monitor” per Masimo’s patent.
Apple argued that the “patient monitor” term refers only to…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
